- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02069470
The Effect of CME on Early Cancer Diagnosis in General Practice
The Effect of Continuing Medical Education (CME) on Early Cancer Diagnosis in General Practice
Background Denmark has a lower survival of cancer compared to most European countries. Fast track pathways for organ specific cancers were established in the years 2008-2010. In 2011 further a fast track pathway for non-specific serious symptoms. Cancer in general practice is a low prevalence condition. Each general practitioner (GP) will see 8-10 new cancer patients per year. The investigators know that cancer patients have an increased use of general practice prior to diagnosis and that 25% of them wait for more than 20 days in general practice for referral according to the GPs. The latest Danish Cancer Plan therefore includes a CME as a key strategy to lower the GP threshold to refer patients to cancer fast track pathways.
The aim of this study was to investigate the effect of this CME in early cancer diagnosis. This is measured by changes in GP knowledge, attitude and risk assessment. GP referral behavior assessed by primary care interval and use of fast track referrals. GP´s cancer hit rate, cancer patients´ tumor stage at treatment and 1 year survival.
Methods/Design The study is conducted as a stepped wedge controlled design based on a quasi-cluster randomization.
In august 2012 an invitation to participate in the present study were sent to 859 general Practitioners (GPs) from the Central Denmark Region. GPs completed a form for each patient they referred to a fast-track diagnostic pathway for cancer within an 8-month period.
Every other week, we received data from a regional database. We reminded the referring GP-practice about non included patients. The collected data will be linked to registries.
The CME-intervention The CME-course was a 3-hour meeting after work. Guided by the available evidence from the literature following the investigators ensured a multifaceted interactive teaching method including case-based education. The content included by other topics positive predictive values, false reassurance from negative testing and other pit-false.
Statistical analyses The outcomes will be analyzed in a generalized linear random-effects model with random effect of GPs. Based on data it will be assessed whether further modeling of inter correlation within practices and within clusters is required, and whether the intervention effects are assumed equal for all GPs, or in random interaction with them. Analyses will be performed both in the full GP-population ("intention to intervening ") and in the 3 subgroups of GPs.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Denmark has a lower survival of cancer compared to most European countries. This could be explained by an inadequate organization of cancer investigation. In order to improve this, 34 fast track pathways for organ specific cancer diseases were established in the years 2008-2010. In 2011 further a fast track pathway for non-specific serious symptoms.
Another reason could be delay in general practice. Cancer in general practice is a low prevalence condition. Each general practitioner (GP) will see 8-10 new cancer patients per year. 50 % of cancer patients presented non-specific symptoms and even when they had organ specific alarm symptoms the positive predictive value for cancer was most often lower than 5%.
The investigators know that cancer patients have an increased use of general practice prior to diagnosis and that 25% of them wait for more than 20 days in general practice for referral. A study showed that 20 % of Danish GPs assumed a hypothetical cancer risk higher than 50% when they refer a 50 year old man to a cancer fast-track pathway. The latest Danish Cancer Plan included a CME as a key strategy to lower the GP threshold to refer patients to cancer fast track pathways.
The aim of this study is to investigate the effect of this CME in early cancer diagnosis. This is measured by changes in
- GP knowledge, attitude and risk assessment.
- GP referral behavior assessed by primary care interval and use of fast track referrals.
- GP´s cancer hit rate, cancer patients´ tumor stage at treatment and 1 year survival.
Methods/Design The study was conducted as a stepped wedge controlled design based on a quasi-cluster randomization. GPs from a cluster which had received CME were controlled by GPs from another cluster which had not yet received CME. GPs from each cluster were divided in an intervention group and a reference group depending on whether they participated in the CME or not.
In august 2012 an invitation to participate in the present study were sent to 859 general Practitioners (GPs) from the Central Denmark Region. GPs were asked to complete a form for each patient they referred to a fast-track diagnostic pathway for cancer within an 8-month period (September 2012 - May 2013). Data included presented symptoms, a GP-estimated cancer risk (predictive value) at referral time, date for referral and date for first presentation of a cancer related symptom to a general practitioner.
To increase the completeness of data, every other week, the investigators received data from a regional database on patients referred to a cancer diagnostic pathway. The referring GP-practice were reminded about non-included patients.
In order to link the collected data following registries were used:
- The Civil Registration Number (CRN), a unique 10-digit personal identification number assigned to every permanent and temporary Danish Residents
- The Hospital Discharge Registry that comprises The Patient Administrative System (PAS) which holds administrative information on hospital activities. Data includes dates of hospital admissions and type of admission.
- The Danish Cancer Registry (DCR) which holds information on all cancer diagnoses in Denmark.
- MedCom data from a web interface (referral hotel) that includes all electronic referral letters sent from general practice to hospital.
- Danish National Health Insurance Service Registry (NHSR) which holds information on all contacts to general practice and all services provided.
The CME-intervention The CME-course was a 3-hour meeting. Guided by the available evidence from the literature following issues were considered important.
- A multifaceted interactive teaching method.
- Knowledge transfer based on patient cases to create a close relation to every day practice.
- An emotional experience to facilitate change in attitude. An educational film was created for the occasion. The film illustrated a series of consultations between a GP and a patient.
Following topics were chosen:
- Faster investigation increases survival.
- Predictive positive values for cancer symptoms.
- False reassurance from a negative test and other pit falls.
- Delay in making an appropriate cancer referral.
- Difficulties in using fast track pathways for cancer.
- Difficulties in communicating cancer risk.
Statistical analyses The outcomes will be analyzed in a generalized linear random-effects model with random effect of GPs. Based on data it will be assessed whether further modeling of inter correlation within practices and within clusters is required, and whether the intervention effects are assumed equal for all GPs, or in random interaction with them. Analyses will be performed both in the full GP-population ("intention to intervening ") and in the 3 subgroups of GPs; GP participated in CME, Colleague participated, even GP neither colleagues participated in CME.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Aarhus C
-
Aarhus, Aarhus C, Denmark, 8000
- Research Centre for Cancer Diagnosis in Primary Care, Research Unit for General Practice, Aarhus University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- GP should be a GP principal
- The referring GP should complete the registration form
- Patients should be referred directly from practice to hospital on cancer suspicion in the inclusion period September 2012- May 2013
Exclusion Criteria:
- Patients already registered with one cancer, diagnosed within 5 years
- Patients self-inflicted in delay
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Usual care
|
|
Experimental: Continuing Medical Education
|
3-hour after work meeting.
Multifaceted form.
Content: Cancer symptoms positive predictive values, pit falls, reflections on barriers and attitudes towards early cancer diagnosis.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Primary care interval
Time Frame: 8 months
|
Primary care interval is the amount of days from the date where the patient first presented a cancer relevant symptom to the GP to the date of referral to a fast track pathway for cancer.
|
8 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Use of fast track referrals
Time Frame: 8 months
|
Use of fast track referrals is measured by counting the relevant electronic referral letters sent to a web interface called referral hotel (MedCom data) from each individual GP in Central Denmark Region.
|
8 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
GP knowledge, attitude and likely behavior pre CME
Time Frame: Average 1 month before CME
|
GP knowledge and attitude are measured by ad hoc questions from an online questionaire.
The answers will be dichotomized
|
Average 1 month before CME
|
Risk assessment
Time Frame: 8 months
|
Risk assessment is measured as a risk of cancer (0%-100%) each time a GP refers a patient to a fast track pathway
|
8 months
|
The concrete patient´s use of general practice half year prior to diagnosis
Time Frame: 6 months
|
Patients use of general practice prior to diagnosis is measured as a ratio.
The denominator is the amount of visits to general practice half year prior to diagnosis.
The nominator is an average use of general practice over a half year based on the last years.
The data is registered in health care registry.
|
6 months
|
GP cancer hit rate
Time Frame: 8 months
|
GP Cancer hit rate per is measured as a proportion between patients referred to a fast track pathway diagnosed with cancer related to the total amount of referred patients.
Civil registration numbers of all referred patients per GP from the MedCom data will be merge with National Registry of Cancer (NRC).
|
8 months
|
Tumor stage
Time Frame: 8 months
|
Cancer patients´ tumor stage at treatment is measured by TNM-stage from Danish Cancer Registry.
|
8 months
|
GP knowledge, attitude and likely behavior after CME
Time Frame: Average 7 months after CME
|
GP knowledge and attitude are measured by ad hoc questions from an online questionaire.
The answers will be dichotomized
|
Average 7 months after CME
|
1 year survival
Time Frame: 1 year
|
Cancer patients´ 1 year survival is measured by merging their Civil Registration Numbers with the Cause of Death Register.
|
1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Peter Vedsted, PhD, Prof., Research centre for Cancer Diagnosis in Primary Care (CaP), Research Unit for general practice, Aarhus University
- Study Director: Flemming Bro, DrMed, Prof, Research Unit for General Practice, Aarhus University
Publications and helpful links
General Publications
- Toftegaard BS, Bro F, Falborg AZ, Vedsted P. Impact of a continuing medical education meeting on the use and timing of urgent cancer referrals among general practitioners - a before-after study. BMC Fam Pract. 2017 Mar 21;18(1):44. doi: 10.1186/s12875-017-0607-3.
- Toftegaard BS, Bro F, Falborg AZ, Vedsted P. Impact of continuing medical education in cancer diagnosis on GP knowledge, attitude and readiness to investigate - a before-after study. BMC Fam Pract. 2016 Jul 26;17:95. doi: 10.1186/s12875-016-0496-x.
- Toftegaard BS, Bro F, Vedsted P. A geographical cluster randomised stepped wedge study of continuing medical education and cancer diagnosis in general practice. Implement Sci. 2014 Nov 7;9:159. doi: 10.1186/s13012-014-0159-z.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BST-5.2013-PV
- BST040373-AAU (Registry Identifier: Berit Skjoedeberg Toftegaard)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
University of Michigan Rogel Cancer CenterRecruitingCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterHyundai Hope On WheelsRecruitingCancer | Pediatric Cancer | Survivorship | Cancer MetastaticUnited States
-
Vanderbilt-Ingram Cancer CenterNational Institutes of Health (NIH)Active, not recruitingAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Breast Cancer | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage... and other conditionsUnited States
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Colon Cancer | Hepatobiliary CancerUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
-
Johns Hopkins UniversityNational Cancer Institute (NCI); National Institute on Minority Health and...Enrolling by invitationCancer | Advanced Cancer | End Stage Cancer | MalignancyUnited States
Clinical Trials on Continuing Medical Education
-
Pham Ngoc Thach University of MedicineEnrolling by invitation
-
Huashan HospitalUnknown
-
University of North Carolina, Chapel HillCompletedEarly Childhood Dental CariesUnited States
-
University of AarhusDanish Cancer Society; TrygFonden, DenmarkWithdrawnChronic Obstructive Pulmonary Disease | Metastatic CancerDenmark
-
Duke UniversityUniversity of Alabama at BirminghamCompleted
-
Qure Healthcare, LLCCE OutcomesCompletedDepression | Heart Failure | Pain | Hypertension | Diabetes | Osteoarthritis | AsthmaUnited States
-
Delfi Diagnostics Inc.Recruiting
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do SulCompleted
-
King Khalid UniversityUnknown
-
Queen's UniversityUniversity of British Columbia; University of Calgary; Laurentian UniversityUnknownDiabetes Mellitus Type 2 | Cultural CompetencyCanada